文献速递垂体与肾上腺疾病

慢性疲劳综合征中的下丘脑-垂体自身免疫与激素分泌受损

Hypothalamic-Pituitary Autoimmunity and Related Impairment of Hormone Secretions in Chronic Fatigue Syndrome.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

患者AHA阳性率33%、APA阳性率56%,ACTH/皮质醇及GH峰值/IGF-1显著低于对照;高滴度(≥1:32)患者激素降低更明显且ME/CFS更严重。结论提示高滴度AHA和/或APA与下丘脑/垂体功能障碍相关,可能参与ME/CFS表现。

要点

  • ME/CFS女性患者APA阳性率56%、AHA阳性率33%,显著高于对照。
  • 高滴度(≥1:32)自身抗体患者ACTH/皮质醇和GH峰值/IGF-1更低。
  • 高滴度抗体与更严重的ME/CFS临床表现相关。

核心结论

  • 高滴度AHA和/或APA与下丘脑/垂体功能障碍相关,提示下丘脑/垂体自身免疫可能在ME/CFS尤其是严重形式中起重要作用。

研究设计与样本

  • 病例对照研究,在斯坦福(美国加州)和那不勒斯(意大利)大学医院开展。
  • 采用免疫荧光检测APA和AHA,并评估垂体前叶及相应靶腺激素分泌。

主要发现

  • 组1患者AHA阳性率为33%,APA阳性率为56%。
  • 组1患者ACTH/皮质醇及GH峰值/IGF-1水平显著低于对照(对照均AHA/APA阴性)。
  • 组1A(13例高滴度阳性,≥1:32)ACTH/皮质醇和GH峰值/IGF-1显著低于组1B(7例中低滴度阳性,1:16-1:8)和组1C(10例抗体阴性),且ME/CFS更严重。

关键数值与推荐

  • ME/CFS诊断依据Fukuda、加拿大和医学研究所标准。
  • 抗体滴度分组:高滴度≥1:32(组1A),中低滴度1:16-1:8(组1B),抗体阴性(组1C)。

临床怎么用

  • 对ME/CFS患者,尤其严重表型,可考虑评估下丘脑/垂体自身抗体及相应激素轴功能。
  • 发现高滴度APA/AHA时,应关注ACTH/皮质醇和GH/IGF-1轴受损可能。

局限性

  • 病例对照设计不能确定自身免疫与ME/CFS的因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe chronic illness that reduces the quality of life. A potential role of neuroendocrine autoimmune dysfunction has been hypothesized. OBJECTIVE: This work aims to investigate the occurrence of antipituitary (APA) and antihypothalamic (AHA) antibodies and possible related hypothalamic/pituitary dysfunctions in ME/CSF patients. METHODS: This is a case-control study conducted in a university hospital setting (Stanford, California, USA; and Naples, Italy). Thirty women with ME/CSF (group 1) diagnosed according to Fukuda, Canadian, and Institute of Medicine criteria, at Stanford University, were enrolled and compared with 25 age-matched healthy controls. APA and AHA were detected by immunofluorescence; moreover, we investigated hormonal secretions of anterior pituitary and respective target glands. APA and AHA titers both were assessed and the prevalence of pituitary hormone deficiencies was also investigated. RESULTS: Patients in group 1 showed a high prevalence of AHA (33%) and APA (56%) and significantly lower levels of adrenocorticotropin (ACTH)/cortisol, and growth hormone (GH) peak/insulin-like growth factor-1 (IGF-1) vs controls (all AHA/APA negative). Patients in group 1A (13 patients positive at high titers, ≥ 1:32) showed ACTH/cortisol and GH peak/IGF-1 levels significantly lower and more severe forms of ME/CFS with respect to patients in group 1B (7 positive at middle/low titers, 1:16-1:8) and 1C (10 antibody-negative patients). CONCLUSION: Both AHA and/or APA at high titers were associated with hypothalamic/pituitary dysfunction, suggesting that hypothalamic/pituitary autoimmunity may play an important role in the manifestations of ME/CFS, especially in its more severe forms.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. De Bellis A, Bellastella G, Pernice V, et al. Hypothalamic-Pituitary Autoimmunity and Related Impairment of Hormone Secretions in Chronic Fatigue Syndrome. J Clin Endocrinol Metab. 2021. PMID: 34254637. doi:10.1210/clinem/dgab429

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。